|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net profit (loss) | |||||
| Adjustments required to reconcile net loss to net cash used in operating activities: | |||||
| Share-based compensation | |||||
| Depreciation | |||||
| Decrease in severance pay, net | |||||
| Loss (gain) from property and equipment sales and disposals | |||||
| Exchange rate differences gain on cash balances | |||||
| Decrease (increase) in interest receivables from short-term bank deposits and long-term restricted deposit | |||||
| Amortization of discount and accrued interest on marketable securities | |||||
| Decrease (increase) in trade receivables | |||||
| Decrease (increase) in other accounts receivable and prepaid expenses | |||||
| Decrease (increase) in long-term prepaid expenses | |||||
| Decrease in operating lease right of use asset | |||||
| Increase (decrease) in trade payables and employees and related accruals and accrued expenses | |||||
| Increase (decrease) in trade payables | |||||
| Increase (decrease) in employees and related accruals | |||||
| Increase (decrease) in accrued expenses | |||||
| Total increase (decrease) in trade payables and employees and related accruals and accrued expenses | |||||
| Decrease in deferred participation in R&D expenses | |||||
| Increase (decrease) in deferred revenues | |||||
| Decrease in operating lease liability | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from maturity of short-term bank deposits | |||||
| Investment in short-term bank deposits | |||||
| Proceeds from maturity of marketable securities | |||||
| Investment in marketable securities | |||||
| Investment in long term restricted deposit | |||||
| Purchase of property and equipment | |||||
| Costs of disposal of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of ordinary shares, net | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from exercise of share-based awards | |||||
| Payments of tax withholding for share-based compensation | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | |||||
| Cash, cash equivalents and restricted cash at the end of the year | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Purchase of property and equipment | |||||
| Right-of-use asset obtained in exchange for operating lease liability | |||||
| Interest payments received from short-term bank deposits and cash equivalents | |||||
| Issuance expenses of ordinary shares | |||||
| Tax paid during the year for Taxes of income | |||||
| Tax paid during the year for Taxes of income | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...
